Application:

This product is used for adult patients with heart attack, stroke, and pulmonary embolism. This drug should be taken ASAP after the stroke (preferably up to 4-5 hours after the onset of stroke symptoms) to achieve the desired result. ALTEPLASE has a relatively small effect on free, circulating plasminogen and can be called a fibrinspecific thrombolytic. In recent years, this drug has played a significant role in saving the lives of patients and reducing the damage caused by these perilous diseases. Specialists have found that in patients with stroke, for every minute that treatment with this product starts faster, 1.8 days will be added to the patient’s life without disability (DFLE).